当前位置: 首页 > 详情页

Increased beta-catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [3]Beijing Renhe Hosp, Dept Neurol, Beijing 102699, Peoples R China
出处:
ISSN:

关键词: beta-catenin c-myc NFPAs aggressive recurrence

摘要:
Non-functional pituitary adenomas (NFPAs) account for 80% of pituitary adenomas with the majority of these exhibiting recurrences post-surgery. Overexpression of beta-catenin and c-myc is common in numerous invasive tumors. The present study sought to investigate the correlation of beta-catenin and c-myc expression levels with aggressive growth and recurrence of NFPAs, using immunohistochemical examination of tissue microarrays. Tissue microarrays comprised 212 NFPAs specimens and 10 healthy specimens as controls. NFPAs were categorized as non-aggressive or aggressive. Immunohistochemical examination was performed to determine the expression of beta-catenin and c-myc. Correlation of the expression levels of beta-catenin and c-myc with clinicopathological parameters, including aggressiveness and recurrence, were assessed by univariate, multivariate and logistic regression analysis. Increased expression of beta-catenin and c-myc was detected in the majority of aggressive NFPAs specimens (71.1 and 88.7%, respectively). There was a significant positive correlation between beta-catenin and c-myc expression and aggressiveness [P=0.001, Odds Ratio (OR)=4.011; P<0.001, OR=30.833]. Only beta-catenin expression demonstrated a significant correlation with recurrence in NFPAs (P=0.021, OR=2.571). beta-catenin and c-myc were demonstrated to be potential biomarkers for aggressive NFPAs and in the future, beta-catenin may serve as a marker for aggressive behavior and recurrence in NFPAs.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院